Stroke Flashcards
Pathophysiology
Ischemic Stroke
Types: cardioembolic vs non-cardioembolic?
Blood clots (thrombus) block blood flow to brain
Thrombus usually formed by cerebral atherosclerotic infarction
Cardioembolic: clot forms in heart and travels to brain
* Common cause: atrial fibrillation
Non-cardioembolic: clot forms in brain, not the heart
Acute treatments for Ischemic Stroke?
- Fibrinolytics
- Blood pressure control (if tPA not given)
- Other treatments (antiplts, HTN management, hyperglycemia, DVT ppx)
Acute treatments for Ischemic Stroke
Fibrinolytics
Medications and dosing?
- Alteplase 0.9 mg/kg (max: 90 mg); 10% given IVP over 1 min, then 90% given IV infusion over 1 hour
- TNKase 0.25 mg/kg (max: 25mg) IVP over 5 seconds; flush with NS
Acute treatments for Ischemic Stroke
Fibrinolytics
tPA exclusions
Not hemorrhagic stroke
No active bleed – in non-compressible areas
No INR >1.7
No prior stroke/TIA (within 3 months)
No prior head trauma (within 3 months)
No BP >185/110
No LMWH within 24h OR DOAC within 48h
Acute treatments for Ischemic Stroke
Fibrinolytics
tPA exclusion; BP control for BP >185/110
BP control (maintain BP <180/105)
*Labetalol 10-20 mg IV push over 1-2 minutes
*Nicardipine 5 mg/hr IV infusion
Clevidipine 1-2 mg/hr IV infusion
Acute treatments for Ischemic Stroke
Fibrinolytics
tPA inclusion
Within 4.5 hours from symptom onset
Within 60 minutes (door-to-needle)
Acute treatments for Ischemic Stroke
Blood pressure control
Permissive HTN: 220/120
MD will allow BP < 220/120 and hold/decrease meds up to 48 hrs after stroke
Rationale: increase BP, increase blood flow/perfusion
Acute treatments for Ischemic Stroke
Other treatments: antiplatelets
- Aspirin 160-325 mg AFTER 24 hours of tPA, but within 48 hours of stoke onset
- Clopidrogel 300-600 mg
- Short-term DAPT (ASA + Plavix) – indicated for patients with TIA or acute ischemic stroke who can swallow and do not have a known cardioembolic source of presentation
Acute treatments for Ischemic Stroke
Other treatments: Hypertension management
Goal: <185/110
Maintain <180/105
Medications: labetalol, nicardipine, clevidipine
Acute treatments for Ischemic Stroke
Other treatments: Hyperglycemia management
Goal: 140-180 mg/dL
Acute treatments for Ischemic Stroke
Other treatments: Deep Vein Thrombosis (DVT) prevention
Intermittent Pneumatic Compression (IPC) devices – squeeze legs to increase blood flow
Medications: UFH, LMWH (only after 24h of receiving alteplase)
Secondary Prevention (outpatient) for Ischemic Stroke?
- Hypertension
- Dylipidemia
- Afib management – for cardioembolic
- Antiplts – for non-cardioembolic
Secondary Prevention for Ischemic Stroke
Hypertension management
Goal: BP <130/80
ACEi and thiazide-type diuretics
Secondary Prevention for Ischemic Stroke
Dyslipidemia
Goal: LDL >70
High-intensity statins – Lipitor 40-80 mg, Crestor 20-40 mg
Secondary Prevention for Ischemic Stroke
Atrial fibrillation
for cardioembolic
Anticoagulants